Tag: wearable biosensor

  • LifeSignals UbiqVue 2A Biosensor Achieves EU Certification

    LifeSignals UbiqVue 2A Biosensor Achieves EU Certification

    The LifeSignals UbiqVue 2A is now officially certified under the EU MDR (European Union Medical Device Regulation), which allows it to be marked with the CE symbol. This means it can be utilized in medical environments throughout the EU.

    Connectivity Features

    This wearable device incorporates 802.11b Wi-Fi, Bluetooth 5.2 LE, and MBAN wireless technologies. Such features enable the unit to transmit 12 different health parameters, in addition to data on falls, movement, and posture, directly to healthcare professionals remotely. All data transfers comply with HIPAA and GDPR regulations to ensure privacy. If there is no data communication, the internal memory can keep information for as long as 12 hours. The device is powered by a lithium manganese dioxide (LiMnO2) battery, which lasts up to five days for a single use.

    Advantages for Healthcare Providers

    With the UbiqVue 2A, the need for multiple devices is significantly lessened, making it easier for healthcare workers and patients alike. Key health metrics monitored include blood oxygen saturation, heart rate, respiratory rate, and body temperature. Additionally, the device features a two-channel electrocardiogram, offering deeper insights into the well-being of heart patients during their recovery. Individuals with heart issues can also keep track of their condition using a smartphone alongside the KardiaMobile Personal EKG Monitor, which is available for purchase on Amazon.

    Monitoring Capabilities

    The biosensor is equipped with a gyroscope and accelerometer that continually track patient movements and their positions, allowing healthcare providers to be alerted to potential issues such as falls. The device measures 4.6 x 3.6 x 0.7 inches (116 x 91 x 17 mm), weighs 1.23 ounces (35 g), and has an IP24 rating for resistance against water splashes.

    LifeSignals, press release from LifeSignals, LifeSignals Group on YouTube

    December 4, 2024

    This cloud-based system, including a wearable biosensor designed for chest-based SpO2 monitoring, supports ongoing patient observation in both hospital and at-home care environments.

    Source: Link


    Image 1
    Image 1
  • Persperity Health Secures $1M for Innovative Sweat-Sensing Wearable

    Persperity Health Secures $1M for Innovative Sweat-Sensing Wearable

    Persperity Health, a new start-up focused on creating a wearable device aimed at helping women oversee their fertility and menopause, has successfully secured $1 million in pre-seed funding. Their innovative technology relies on non-invasive sweat analysis instead of traditional blood tests to assess hormone levels.

    Innovative Technology

    The company has developed a unique, patented ring-shaped biosensor that utilizes sweat-sensing technology. This invention is the brainchild of co-founder Dr. Wei Gao and is exclusively licensed from Caltech. Users won’t have to endure intense workouts to gauge hormone levels; instead, they can rely on a painless technique called iontophoresis, which induces sweating on demand.

    Hormone Detection

    Persperity Health claims that various hormones, including estradiol, progesterone, and luteinizing hormone (LH), can be identified through sweat. The firm highlights three main scenarios where hormone tracking can be especially beneficial: recognizing early signs of hormonal imbalance, monitoring ovulation to improve fertility treatments, and alleviating menopause symptoms.

    In their announcement, Persperity Health mentioned that the funding will be utilized to "speed up" the development of their product. On their website, they list investors such as FreeFlow, Wilson Hill, Caltech, Alma Capital, and Merkin Family Office. However, the timeline for the launch of the first consumer product from Persperity Health remains uncertain.